Plain-English translation of NCT07543367 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This early-stage trial is testing the Synchron BCI motor neuroprosthesis, an implanted brain-computer interface designed for people with ALS who have lost movement in both arms. The device detects signals from your brain related to movement and translates them to help you control digital devices like computers or tablets. This treatment aims to restore meaningful independence in daily activities for people whose arms are no longer responding to their own motor commands.
ALS gradually weakens the muscles that allow you to move, eventually leaving many patients unable to control their arms or communicate. This trial exists because there is currently no way to restore this lost function — the new treatment offers a potential path to regain control by bypassing damaged nerves and working directly with brain signals.
You likely qualify if…
You likely don't qualify if…
You would undergo a surgical procedure to implant the brain-computer device, which involves placing a tiny sensor in a blood vessel in your brain through a minimally invasive approach. After implantation, you would attend clinical training visits and testing sessions (some in your home) to learn how to use the device to control digital applications. Throughout the study, you would work with the research team to develop control of the device and complete assessments measuring your ability to perform daily tasks — with your caregiver's support throughout the process.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Sponsor
Synchron, Inc.
Enrollment target
~10 participants
Started
April 2026
Primary completion
June 2027
Age range
22 Years and older
Last updated on clinicaltrials.gov in May 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.